Murdoc Khaleghi

Murdoc Khaleghi has an extensive work experience spanning more than a decade. In 2009, they began working as a Health Author for Medical Writer. From 2019 to 2021, they held various positions such as Head of Medical for Rupa Health, Advisor for ORDRS, Board of Directors, Life Science Co-lead for Rockies Venture Club, Board of Directors for NULASTIN®, and Board of Directors, Chief Medical Officer for FOXO Technologies. In 2021, they were also appointed as Chief Medical Officer for Base. In 2022, they were appointed as Chief Medical Officer for Claire. Additionally, they are an Investor for Denver Angels.

Murdoc Khaleghi obtained a Bachelor of Science in Bioengineering from UC San Diego in 2001-2006. Murdoc then attended the University of California, San Diego - School of Medicine and received their MD degree in 2006. From 2011-2012, they attended Columbia Business School and the University of California, Berkeley, Haas School of Business, where they earned a Master of Business Administration (MBA). In 2019-2021, they obtained a Master's degree in Computer Science from the University of Pennsylvania. In addition, they have obtained certifications from the American Board of Emergency Medicine and Lutheran Immigration and Refugee Service.